Research Applications for Raloxifene HCl Studies
Evista DAIICHI SANKYO is a selective estrogen receptor modulator (SERM) containing raloxifene hydrochloride, developed by pharmaceutical manufacturer DAIICHI SANKYO for laboratory research applications. This compound functions as both an estrogen receptor agonist and antagonist depending on tissue type, making it valuable for investigating complex hormonal pathways and receptor selectivity mechanisms in controlled laboratory environments. Researchers at Stroid UK Shop utilise raloxifene preparations to examine estrogen receptor binding affinity, tissue-specific hormonal responses, and molecular mechanisms underlying selective estrogen receptor modulation.
Molecular Mechanisms and Research Properties
Raloxifene hydrochloride demonstrates unique pharmacological characteristics that distinguish it from other compounds in the aromatase inhibitors raloxifene HCl category. The compound exhibits tissue-selective estrogen receptor modulation, acting as an estrogen receptor antagonist in breast and uterine tissues while functioning as an agonist in bone and cardiovascular tissues in preclinical models. Research studies investigate raloxifene’s ability to maintain beneficial estrogenic effects on bone mineral density while blocking potentially harmful estrogenic stimulation in reproductive tissues. Laboratory investigations examine the compound’s interaction with estrogen receptor alpha and beta subtypes, providing insights into selective receptor modulation mechanisms that inform broader hormonal research applications.
Technical Specifications and Research Parameters
| Active Compound | Raloxifene Hydrochloride |
|---|---|
| Manufacturer | DAIICHI SANKYO |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Solubility | Research-grade solvents |
Laboratory research with this SERM preparation involves investigating bone metabolism pathways, estrogen receptor binding kinetics, and tissue-selective hormonal responses. Scientists examine raloxifene’s effects on osteoblast and osteoclast activity in bone tissue cultures, while simultaneously studying its antagonistic properties in breast tissue cell lines. Comparative studies with other compounds available in the SARMs category and peptides section provide valuable insights into selective receptor modulation mechanisms across different molecular classes.
Laboratory Research and Compliance
This raloxifene hydrochloride preparation is manufactured under pharmaceutical standards by DAIICHI SANKYO exclusively for in-vitro laboratory research purposes. Research applications include molecular biology studies, receptor binding assays, tissue culture experiments, and biochemical pathway investigations. The product requires proper laboratory handling procedures and should be stored according to manufacturer specifications to maintain research integrity. This product is sold strictly for laboratory research purposes only and is not intended for human consumption, clinical use, or any application outside of controlled scientific research environments.
